Researchers from The University of Texas at Dallas' Center for Advanced Pain Studies (CAPS) and their colleagues have made a fundamental discovery ...

His latest book project, Sweet Blood: Diabetes and the Nature of Modern Health (currently under contract with Yale University Press), explores how environmental and cultural factors have shaped the ...

EMERYVILLE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with ...

Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company’s registrational KYSA-6 Phase 3 MG trial 100% of patients achieved clinically ...

Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company’s registrational KYSA-6 Phase 3 MG trial 100% of patients achieved clinically ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced results from the Phase III HARMONi-6 trial, conducted in China and sponsored by our ...

HONG KONG, Oct. 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been ...

Los Angeles Rams star wide receiver Puka Nacua is one of the best at his position in the NFL, but he told Fox News Digital this is only his floor of production. He also detailed how he builds a ...

With injuries and bye weeks starting to hit hard, our lineup is no longer full of stars from top to bottom. We have to go a little bit deeper and find some sleepers to plug into our lineups this week.

"That would happen if and when it was something that I couldn't not do," Matthew McConaughey tells PEOPLE of potentially running for public office Andrea Mandell is the Senior Editor of Entertainment ...